MARKET

SLP

SLP

Simulations Plus Inc
NASDAQ
18.36
-0.03
-0.16%
Pre Market: 18.48 +0.12 +0.65% 07:21 07/07 EDT
OPEN
18.38
PREV CLOSE
18.39
HIGH
18.45
LOW
18.34
VOLUME
1.45K
TURNOVER
0
52 WEEK HIGH
21.01
52 WEEK LOW
11.09
MARKET CAP
370.97M
P/E (TTM)
-5.8784
1D
5D
1M
3M
1Y
5Y
1D
Simulations Plus director and 10% owner Walter S. Woltosz sells 4,177 shares worth $77,014.88
PUBT · 12h ago
Johnson Fistel Investigates Simulations Plus Following Revenue Guidance Cut and Accounting Disclosures
PR Newswire · 18h ago
Options Volatility and Implied Earnings Moves This Week, July 07 – July 10, 2026
TipRanks · 1d ago
Weekly Report: what happened at SLP last week (0629-0703)?
Weekly Report · 1d ago
Weekly Report: what happened at SLP last week (0622-0626)?
Weekly Report · 06/29 09:42
Simulations Plus (SLP) Investigation: Investors Who Suffered Losses Encouraged to Contact Johnson Fistel
Barchart · 06/24 11:04
AI Daily: Qualcomm in talks to acquire Modular
TipRanks · 06/23 17:22
Simulations Plus advances agentic drug development with NVIDIA BioNeMet Agent
TipRanks · 06/23 15:46
More
About SLP
Simulations Plus, Inc. specializes in model-informed and artificial intelligence (AI)-accelerated drug development. The Company helps its clients by accelerating the discovery, development, and commercialization of pharmaceuticals and other products through science-based software and consulting solutions. The Company’s segments include Software and Services. The Company's Software segment supports pharmaceutical research, development, and commercialization through simulation, modeling, and AI-driven prediction. Its main products include GastroPlus, ADMET Predictor, MonolixSuite, and others for disease modeling and training, as well as Pro-ficiency for clinical operations. Its Services segment includes advanced consulting services across the entire drug development lifecycle. Its scientists and engineers specialize in drug discovery, pharmacokinetics, pharmacodynamics, drug modeling, clinical trial data analysis, regulatory strategy, and medical communications.

Webull offers Simulations Plus Inc stock information, including NASDAQ: SLP real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SLP stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading SLP stock methods without spending real money on the virtual paper trading platform.